TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 DKK)
Closing information | 2024/06 | 2023/06 | 2022/06 |
Turnover |
397
|
436
|
775 |
Financial expenses |
0
|
30
|
0 |
Earnings before taxes |
48
|
39
|
279 |
EBITDA |
-3
|
68
|
73 |
Total assets |
2,057
|
2,045
|
2,553 |
Current assets |
262
|
185
|
239 |
Current liabilities |
178
|
111
|
217 |
Equity capital |
1,792
|
1,829
|
2,176 |
- share capital |
66
|
63
|
70 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Solvency |
87.1%
|
89.4%
|
85.2% |
Turnover per employee |
397
|
436
|
775 |
Profit as a percentage of turnover |
12.1%
|
8.9%
|
36.0% |
Return on assets (ROA) |
2.3%
|
3.4%
|
10.9% |
Current ratio |
147.2%
|
166.7%
|
110.1% |
Return on equity (ROE) |
2.7%
|
2.1%
|
12.8% |
Change turnover |
-56
|
-266
|
24 |
Change turnover % |
-12%
|
-38%
|
3% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.